Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Delaware Healthcare Fund

+ Add to Watchlist

DLHCX:US

20.61 USD 0.31 1.48%

As of 09:29:30 ET on 05/26/2015.

Snapshot for Delaware Healthcare Fund (DLHCX)

Year To Date: +12.01% 3-Month: +6.13% 3-Year: +27.98% 52-Week Range: 16.57 - 20.92
1-Month: -0.29% 1-Year: +25.26% 5-Year: +22.98% Beta vs RGUSH: 0.90

Mutual Fund Chart for DLHCX

No chart data available.
  • DLHCX:US 20.61
  • 1M
  • 1Y
Interactive DLHCX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DLHCX

Delaware Healthcare Fund is an open-end fund incorporated in the USA. The Fund's objective is to maximize long-term capital growth through capital appreciation. The Fund invests at least 80% of its assets in the equity securities of health care companies.

Inception Date: 01-28-2010 Telephone: 1-800-523-1918
Managers: LIU-ER CHEN "NU"
Web Site: www.delawareinvestments.com/co/delaware

Fundamentals for DLHCX

NAV (on 2015-05-26) 20.61
Assets (M) (on 2015-05-21) 511.59
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 10.00

Dividends for DLHCX

No dividends reported

Fees & Expenses for DLHCX

Front Load 0.00
Back Load 1.00
Current Mgmt Fee 0.85
Redemption Fee 1.00
12b1 Fee 1.00
Expense Ratio 2.10

Top Fund Holdings for DLHCX

Filing Date: 03/31/2015
Name Position Value % of Total
Sanofi 300,000 29,633,226 6.173%
Eli Lilly & Co 387,000 28,115,550 5.857%
Teva Pharmaceutical Industries 450,000 28,035,000 5.840%
Bristol-Myers Squibb Co 341,737 22,042,037 4.592%
Chugai Pharmaceutical Co Ltd 600,000 18,933,398 3.944%
GlaxoSmithKline PLC 400,000 18,460,000 3.845%
UCB SA 249,785 18,048,094 3.760%
Boston Scientific Corp 970,000 17,217,500 3.587%
Quest Diagnostics Inc 220,000 16,907,000 3.522%
SINA Corp/China 485,000 15,597,600 3.249%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil